NovoNordisk Recalls Samples of Insulin Products
May 7, 2021
Zynrelef Approved for Non-Opioid Pain Relief After Surgery
May 13, 2021
NovoNordisk Recalls Samples of Insulin Products
May 7, 2021
Zynrelef Approved for Non-Opioid Pain Relief After Surgery
May 13, 2021

Primary Formulary Changes

Upcoming Formulary Changes

May 7, 2021 - As your Prescription Benefit Facilitator, Global Reach Health is committed to creating value by providing the highest quality service, innovative clinical solutions, and valuable trend management strategies.

Global Reach Health controls trend through several factors, including our unique pass-through model, generic maximization, clinical programs, and formulary management. Global Reach Health continually reviews the latest information available to keep our clinical rules and programs up to date to improve care and reduce costs.

The following change to the Primary Formulary will go into effect on June 1, 2021.

Medication Added to Preferred Status

REDITREX

The following changes to the Primary Formulary will go into effect on July 1, 2021.

Medications Added to Preferred Status
CARBAGLULATUDAVIMPAT
ESTRINGNYVEPRIAZOKINVY
KESIMPTAPLEGRIDY IM
Medications Changed to Preferred Brand Copay

ADVAIR HFA
MITIGARE

Global Reach Health appreciates your trust and support in serving your healthcare needs through your prescription program. If you have any questions, please contact your Pharmacists, or call our Client Services at +1 (855) 898-2548

www.globalreachhealth.com